Doubts raised over Thai boxer's gender

The article reports that Thai bantamweight Usanakorn Kokietgym recorded 'highly suspicious' testosterone levels—about three times the normal female level—before a world title fight in Melbourne. She fought Australian champion Susie Ramadan, who won the 10-round bout. WBC secretary Frank Quill and two physicians interviewed Usanakorn, who denied using steroids and refused blood testing. A report is to be forwarded to the World Boxing Council's Mexican headquarters for investigation.

Officials detected testosterone levels far above the normal female range, prompting speculation about possible causes. The article cites Australian Ringside Medicine Association chairman Peter Lewis, who suggested several explanations mentioned in the report: prior male biology followed by estrogen treatment, anabolic steroid use, or an intersex condition (described there as 'hermaphrodite'). Usanakorn refused blood testing that would have further clarified the issue.

Usanakorn denied taking anabolic steroids or any other drugs when interviewed by WBC secretary Frank Quill and two physicians. However, she refused the blood testing that officials said would have proven her gender. Mr Quill indicated a report would be sent to the WBC's Mexican headquarters, and the organisation is expected to investigate the matter.

The article states the WBC will receive a report and is expected to investigate. While it doesn't specify outcomes, such investigations can lead to formal findings that affect a fighter’s eligibility, titles, rankings and future matchups. Everyday investors tracking sports assets should watch for official WBC decisions because they can alter athlete status and event planning.

The article notes the issue comes as women's boxing is being introduced at the Olympics, so high-profile controversies can draw extra scrutiny. That scrutiny could prompt regulators and sanctioning bodies to review testing and eligibility rules ahead of major events, which can affect the sport’s governance and commercial prospects.

Although the article focuses on the incident, it implies that high-profile disputes—over testosterone levels, gender or alleged drug use—can create reputational risks for promoters, venues and sponsors. Investors in sports-related businesses may face short-term publicity issues, contractual disputes, or pressure to increase compliance and testing protocols.

The article doesn’t cover betting or revenues directly, but controversies that raise doubts about fighter eligibility or prompt investigations typically increase market uncertainty. That can affect betting odds, ticket sales and broadcast interest while investigations are unresolved, so investors and punters often monitor developments closely.

Based on the article, investors should monitor: official WBC investigation updates and any sanctions; statements from the fighters and their teams; changes to testing and eligibility rules for women's boxing; sponsor or broadcaster responses; and any impact on event scheduling or ticket sales. These signals can indicate reputational or regulatory risk that affects sports-related investments.